Schulman C, Pommerville P, Höfner K, Wachs B, Long-term therapy with the dual 5alpha-reductase inhibitor dutasteride is well ... Gli inibitori della 5-alfa-reduttasi continuano a non essere approvati per la prevenzione del cancro alla prostata. Di seguito ... La dose raccomandata di dutasteride è di 0,5 mg, equivalenti a una capsula, una volta al giorno per via orale, con o senza cibo ... 75, n. 5, June 2022, pp. 382-399, DOI:10.56434/j.arch.esp.urol.20227505.56. URL consultato il 12 ottobre 2023. ^ Leliefeld HHJ ...
J. Yaneva, J. Zlatanova, Histone H1 interacts specifically with certain regions of the mouse alpha-globin gene., in DNA Cell ... 20, n. 5, novembre 1977, pp. 680-8, PMID 924691. A. Jemal, T. Murray; E. Ward; A. Samuels; RC. Tiwari; A. Ghafoor; EJ. Feuer; ... 54, n. 5, giugno 2008, p. 1081, DOI:10.1016/j.eururo.2008.06.071, PMID 18602209. ^ Marks LS, Fradet Y, Deras IL, et al., PCA3 ... 532-5, DOI:10.1016/j.urology.2006.12.014, PMID 17382159. ^ ML. Essink-Bot, HJ. de Koning; HG. Nijs; WJ. Kirkels; PJ. van der ...
Bhardwaj; M. Kumar, An overview on 5alpha-reductase inhibitors., in Steroids, vol. 75, n. 2, febbraio 2010, pp. 109-53, DOI: ... an Inhibitor of the Enzyme 5alpha-Reductase, in the Nervous System : Steroid Hormone Actions, Biosynthesis and Metabolism ( ... Altogether these findings suggest that the block of the enzyme 5alpha-reductase by finasteride treatment may have broad ... 73, n. 5, 1º novembre 2009, pp. 770-780, DOI:10.1016/j.mehy.2008.10.039. URL consultato il 28 maggio 2017. ^ Michael S. Irwig e ...
3.0.CO;2-D Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 ... Hair Loss Drugs - Turosteride - competitive and specific inhibitor of Type II 5a-reductase. - Database of Drugs for Hair Loss, ... Seiffert K, Seltmann H, Fritsch M, Zouboulis CC, Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT ... a comparative study of selective inhibitors, in The Journal of Steroid Biochemistry and Molecular Biology, vol. 54, n. 5-6, ...
Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug ... Characterization of sequences at the inhibitor and coenzyme binding sites. Archiviato il 24 gennaio 2009 in Internet Archive. J ... Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. ... PMID 3511964 ^ Hille R, Massey V. Tight binding inhibitors of xanthine oxidase. Pharmacol Ther. 1981;14(2):249-63. PMID 4322209 ...
Reductase and Its Inhibitors, p.167. ^ Zouboulis, Katsambas, Kligman. (2014), Falk R. Ochsendor: Oral Antibiotics, p. 449. ^ ... Cigarette Smoke-Induced Interleukin-1 Alpha May Be Involved in the Pathogenesis of Adult Acne, in Ann Dermatol., vol. 26, n. 1 ... 71, n. 5, novembre 2014, pp. 847.e1-847.e10, DOI:10.1016/j.jaad.2014.05.007, PMID 25437977. ^ Kong YL, Tey HL, Treatment of ... 3, n. 5, 2008, pp. 595-603. URL consultato il 25 aprile 2016 (archiviato dall'url originale l'11 maggio 2016). Ramli R, Malik ...
Mustacich D, Powis G, Thioredoxin reductase, in Biochem J, 346 Pt 1, pp. 1-8, PMID 10657232. ^ Creissen G, Broadbent P, Stevens ... Sowell A, Huff D, Yeager P, Caudill S, Gunter E, Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, ... The Stoichiometry and Fate of Inhibitors in Benzene and Chlorobenzene". Journal of the American Chemical Society, 3233-3235 ^ ... Arnér E, Holmgren A, Physiological functions of thioredoxin and thioredoxin reductase, in Eur J Biochem, vol. 267, n. 20, 2000 ...